ID
14956
Description
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00717951
Link
https://clinicaltrials.gov/show/NCT00717951
Keywords
Versions (1)
- 5/9/16 5/9/16 -
Uploaded on
May 9, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Breast Cancer NCT00717951
Eligibility Advanced Breast Cancer NCT00717951
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
chemotherapy treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C3665472
Description
5-fluorouracil
Data type
boolean
Alias
- UMLS CUI [1]
- C0016360
Description
docetaxol for metastatic disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0246415
Description
cancer
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Advanced Breast Cancer NCT00717951
- StudyEvent: Eligibility
C0948762 (UMLS CUI [2])
C0002059 (UMLS CUI [2])